Listen to this exclusive interview with Peter Stern (University of Manchester, UK) to discover more about chemotherapy resistance in acute lymphoblastic leukemia and novel strategies to overcome it.
Editor, Jade Parker recently spoke with David Adams, Wellcome Trust Sanger Institute (Cambridge, UK) about utilizing DNA sequencing of patients and genetic screens in human cells and mice to identify cancer genes and genetic interactions.
In this interview with Francesco Lo-coco we discussed a randomized clinical trial conducted with the drug Trisenox as well as, the genetic characterization, monitoring and treatment of hematologic tumors, particularly acute promyelocytic leukemia.
Editor Jade Parker, speaks to Peter Campbell (Wellcome Trust Sanger Institute, Cambridge, UK) to find out how he is working towards identifying the preventable causes of cancer.
In an exclusive interview, Greg Hannon from Cancer Research UK Cambridge Institute (UK), speaks to Oncology Central about his Grand Challenge project to create a virtual reality tumor.
This interview with Simon Noble discusses pallitive cancer care development with an emphasis on the management of venous thromboembolism in advanced cancer
In this exclusive interview, Gopalan Narayanan from Voisin Consulting Life Sciences (UK), speaks about whether there are sufficient resources available to clinicians looking to adopt biosimilar’s, regulatory challenges during ATMP development and the potential of both of these products to transform the treatment of complex diseases.
To mark our focus on social media in cancer care we recently spoke with Deanna Attai from the University of California (CA, USA) about the potential use of social media in cancer care including how oncologists can incorporate social media into their care plans as well as the opportunities and risks they should be aware of
Lydia Makaroff of the European Cancer Patient Coalition (ECPC, Brussels, Belgium) speaks with Oncology Central about the goals and upcoming projects for the ECPC in 2017.
As part of our spotlight on Interventional Oncology, Oncology Central spoke with Tobias Jakobs from the Hospital In the Order of St. John of God (Munich) about his thoughts on DC Bead LUMI™ including how it may aid post procedural imaging.